In atypical hemolytic uremic syndrome (aHUS), cytokines are upregulated secondary to complement dysregulation, while in thrombotic thrombocytopenic purpura (TTP), inflammation may lower ADAMTS13 activity and potentiate thrombosis. Here, ADAMTS13 is linked to atypical hemolytic-uremic syndrome.